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Abstract. Townes-Brocks syndrome (TBS) is a rare autosomal 
dominant congenital anomaly syndrome characterized by 
the triad of anorectal, hand and external ear malformations. 
Kidney involvement is less common and may progress to 
end-stage renal failure (ESRF) early in life. The present study 
reports the case of a male patient presenting with multiple 
bilateral cortical kidney cysts at the age of 4 years, at which 
time the kidneys were of normal size and function. A clinical 
diagnosis of autosomal recessive polycystic kidney disease 
was made initially as the patient's parents are clinically 
healthy. However, the consideration of extra-renal involve-
ments (imperforate anus at birth, preaxial polydactyly and 
dysplastic right ear) following the progression of the patient 
to ESRF at the age of 16 years, led to the diagnosis of TBS. 
This prompted sequencing of the SALL1 gene, which identi-
fied a novel heterozygous nonsense mutation in the mutational 
‘hotspot’ of exon 2 (c.874C>T, p.Q292X), and this mutation 
was not detected in healthy controls. The current case high-
lights that TBS may present with normal sized, cystic kidneys 
in childhood, while recognition of extra-renal features of cystic 
kidney diseases, such as TBS, and genetic testing may facili-
tate the correct diagnosis and transmission mode. Reaching a 
correct diagnosis of as TBS is important since this condition 
has a 50% rate of transmission to offspring and can progress 
to ESRF early in life.
Introduction
Multiple renal cysts present clinical features in a range 
of kidney diseases that may be inherited as dominant or 
recessive traits (1). Autosomal dominant diseases include 
autosomal dominant polycystic kidney disease (ADPKD), 
which is by far the most common inherited cause of kidney 
cysts worldwide, as well as HNF1B-associated kidney 
disease, medullary cystic kidney disease (MCKD) and cystic 
neoplasms (such as Von Hippel-Lindau disease and tuberous 
sclerosis complex) (2). Although these conditions may present 
in children, they often cause adult-onset kidney disease, and a 
family history of kidney problems is frequently reported (3). 
Recessive conditions commonly present in childhood and often 
occur in the absence of a relevant family history. They include 
autosomal recessive polycystic kidney disease (ARPKD), 
nephronophthisis (NPHP) and multi-system ciliopathies, such 
as Bardet-Biedl, Joubert and Meckel-Gruber syndromes (4).
A range of other uncommon disorders characteristically 
presents with congenital abnormalities of the kidney and 
urinary tract (CAKUT), but may also manifest as cystic kidney 
disease (5). These diseases include: Townes-Brocks syndrome 
(TBS), which is caused by mutations in SALL1; renal colo-
boma syndrome, which is associated with PAX2 mutations; 
oral facial digital syndrome type 1, which is due to mutations 
in gene OFD1; and other disorders that frequently include 
extra-renal manifestations (6). Imaging features of these disor-
ders are variable and may overlap, while renal histology is 
frequently unavailable or does not help the diagnosis (7). Thus, 
recognition of extra-renal features is of critical importance in 
establishing the correct diagnosis. This is particularly valuable 
in cases where no family history is available, and therefore 
the differential diagnosis includes both dominant and reces-
sive conditions. The mode of transmission determines whether 
there is a risk that other family members may be affected, thus 
affecting reproductive decision‑making. Confirmation of the 
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diagnosis by genetic testing can therefore be clinically valu-
able in this context.
The current study presents the case of a 16-year-old male 
patient with autosomal dominant TBS, who was initially 
incorrectly diagnosed as having ARPKD. Appreciation of 
extra‑renal features prompted genetic testing that confirmed 
the correct diagnosis of an autosomal dominant disease, which 
has significant implications for the patient and family members.
Case report
The proband was a 16-year-old male who was referred 
to XinHua Hospital (Shanghai, China) in May 2014 with 
end-stage renal failure (ESRF) and a serum creatinine (Scr) 
level of 932 µmol/l (normal range, 35-97 µmol/l). The patient 
had been found to have proteinuria of 30-300 mg/dl (normal 
range 0-20 mg/dl)) with no hematuria following an upper respi-
ratory infection at the age of 4 years, in April 2002. There was 
no family history of kidney disease and his clinically healthy 
parents were not consanguineous. Ultrasound examination 
at the age of 4 years demonstrated that the patient's kidneys 
were a normal size for his age [left kidney, 69x33 mm; right 
kidney, 58x31 mm; reported normal kidney lengths for a 
4-year-old, 70.30±5.20 mm (8)] with multiple bilateral cortical 
cysts (largest cyst, 10x17 mm). The Scr level (45 µmol/l) and 
blood pressure were within the normal range at that time. Liver 
function tests and hepatic imaging were also normal. The lack 
of family history and childhood onset of disease suggested 
a diagnosis of ARPKD, while ADPKD was also considered 
possible by the treating clinicians. The renal function gradu-
ally deteriorated and the Scr reached a level of 400 µmol/l at 
the age of 15 years, with renal dialysis commencing at the age 
of 16 years at the Dialysis Center of XinHua Hospital.
Upon reviewing the medical history, it was found that the 
patient had an imperforate anus at birth, which was surgi-
cally repaired when he was 3 months old, as well as pre-axial 
polydactyly of both hands, which was surgically corrected 
when the patient was 3 years old. The patient was also 
reported to have exhibited mild bilateral hearing loss since 
the age of 5 years. However, no growth retardation or learning 
difficulties were reported. Physical examination revealed a 
dysplastic right ear with overfolded superior helices (Fig. 1A), 
as well as bilateral surgically corrected thumbs (Fig. 1B). 
Renal ultrasound examination performed on an Ultrasound 
LOGIQ 500 (GE Healthcare Milwaukee, WI, USA) showed 
bilateral small kidneys (left kidney, 74x36 mm; right kidney, 
59x31 mm) with multiple cortical and medullary cysts, 
ranging between 10 and 17 mm (Fig. 1C). No other urinary 
tract structural abnormality was identified, imaging assess-
ments did not detect any abnormalities of the liver, spleen or 
pancreas, and an echocardiogram was normal. The parents 
were clinically unaffected and no family history of genetic 
disease was reported.
Based on the aforementioned extra-renal features, a 
diagnosis of TBS was suspected. Following approval by the 
Ethical Committee of Shanghai XinHua Hospital according 
to the standards of the Declaration of Helsinki and the 
signed informed consent obtained from the proband, DNA 
was extracted from the proband's peripheral blood. SALL1 
gene coding regions and splice sites were amplified and 
directly sequenced using an ABI PRISM 3730xl Genetic 
Analyzer (Applied Biosystems; Thermo Fisher Scientific, 
Inc., Waltham, MA, USA) as reported previously (9), (SALL1 
sequencing primer sequences are available upon request). 
Sequencing analysis disclosed a novel SALL1 heterozygous 
nonsense mutation located in the mutational ‘hotspot’ of 
Figure 1. (A) Right ear of the proband with overfolded superior helices. (B) Surgically corrected thumbs of the proband's hands. (C) Renal ultrasound showed 
multiple cysts arising from the cortex and medulla of the left and right kidneys.
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exon 2 (c.874C>T, p.Q292X; Fig. 2A), and this mutation was 
not present in the 100 unrelated healthy adult volunteers 
(all of whom provided informed consent, were free from 
renal disease and matched geographically) used as controls 
(Fig. 2B). The parents of the proband declined genetic testing, 
however it appears likely that this represents a de novo muta-
tion, which is estimated to occur in ~50% of patients with 
TBS (10), as the parents of the proband are clinically healthy. 
It is also possible that one of the parents carries the mutation 
in a mosaic state, as germline mosaicism in clinically unaf-
fected parents has been reported in TBS cases (11). As the 
patient had reached ESRF at the time of genetic diagnosis, the 
patient remained on maintenance hemodialysis three times 
per week until the final follow‑up in March 2015.
Discussion
TBS has a prevalence of 1 in 250,000 individuals in the 
general population (12). It is a rare autosomal dominant 
malformation syndrome characterized by the core triad of 
anorectal malformation (imperforate anus, anteriorly-placed 
anus and anal stenosis), hand malformations (pre-axial poly-
dactyly, triphalangeal thumbs and bifid thumb) and external 
ear malformation (preauricular ear tags and overfolding of 
ear helices) associated with deafness (13). TBS is confirmed 
by identification of a pathogenic mutation in SALL1 with 
the detection rate of 64-83% (14). SALL1 is a human gene 
homologous to the developmental regulator sal of Drosophila 
melanogaster, which is considered to be an essential organo-
genesis regulator for urological, renal, limb, ear, brain and 
liver development (15).
Sall1 protein, encoded by SALL1, is abundantly expressed 
in embryonic kidneys and plays a pivotal role in mammalian 
nephrogenesis by controlling the expression of major renal 
development genes, including PAX8, GDNF and FOXD1 (16). 
Mice with homozygous deletion of Sall1 (SALL1-/-) have been 
observed to succumb to death in the perinatal period due to 
renal agenesis or severe dysgenesis (17), while another mouse 
model expressing a truncated N-terminal protein (Sall1-N) 
recapitulated human TBS renal defects of renal hypoplasia 
with or without cysts (18). The incidence of renal anomalies 
in TBS patients ranges between 20 and 62.5%, with hetero-
geneous phenotypes including unilateral or bilateral renal 
hypoplasia or dysplasia, renal agenesis, multicystic kidneys, 
vesicoureteral reflux, posterior urethral valve or meatal 
stenosis (19). In addition, renal hypodysplasia has also 
been reported as an isolated TBS phenotype (20). A study 
involving 749 patients with CAKUT revealed that SALL1 
mutations account for >20% of all the identified mutations 
(9 out of 37 mutations), indicating that this mutation is more 
common than was expected (21). Therefore, kidney imaging is 
recommended for TBS patients and in case presenting renal 
anomalies. Furthermore, close monitoring of renal function 
and appropriate medical interventions are indicated, as TBS 
has been reported to be associated with early-onset renal 
failure with nearly 15% of TBS patients with renal anomalies 
progressing to ESRF between the ages of 1 and 23 years (19).
The patient reported in the present study harbored a novel 
heterozygous nonsense mutation (c.874C>T, p.Q292X) in the 
SALL1 mutational hotspot region. This mutational hotspot 
region is located within exon 2 between nucleotide 765, 3' of 
nucleotides 687-750 encoding the glutamine-rich interaction 
domain, and nucleotide 1565, 3' of the region encoding the 
first double zinc finger domain (22). Frameshift and nonsense 
SALL1 mutations occur in this mutational hotspot region, such 
as the most common SALL1 heterozygous mutation, which is 
c.826C>T, p.R276X. These mutations are usually associated 
with classical TBS and a more severe phenotype, including 
renal failure (10,19,22), which suggests a dominant-negative 
or gain-of-function mechanism caused by the abnormal 
truncated Sall1 protein. In comparison, haploinsufficiency 
for SALL1 caused by heterozygous large or whole gene dele-
tions have been described in milder TBS cases (9). Only one 
previous study has described renal insufficiency and ESRF in 
two Japanese adolescent patients with 16q12 microdeletion 
including the entire SALL1 gene (23).
In the present TBS case, the correct diagnosis was delayed 
until the patient reached ESRF, suggesting that recognition 
of extra-renal features is of critical importance in making a 
diagnosis in cystic kidney diseases, particularly when renal 
imaging is atypical. The possibility that clinical features of 
TBS may overlap with other rare developmental syndromes 
such as VACTERL association (24), Goldenhar syndrome (25) 
and branchiootorenal (BOR) syndrome (26), should also be 
considered. Additional features, such as vertebral abnormali-
ties and trachea‑esophageal fistula in VACTERAL association, 
craniofacial abnormalities in Goldenhar syndrome and bran-
chial arch anomalies in BOR syndrome, may aid the diagnosis 
of these disorders.
In conclusion, the present case illustrated that TBS may 
present with normal-sized cystic kidneys in childhood. 
Recognition of extra-renal features of cystic kidney diseases, 
such as TBS, and genetic testing may facilitate the correct 
Figure 2. Sanger sequencing electropherograms showed that (A) the proband 
has the SALL1 heterozygous mutation (c.874C>T, p.Q292X), (B) which was 
not detected in 100 healthy Chinese controls.
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diagnosis, which is necessary to give the correct advice to 
patients and their families regarding the mode of transmis-
sion and consequent risk to relatives and offsprings of those 
affected. As TBS can cause ESRF early in life, renal imaging 
and close monitoring of renal function are recommended for 
TBS patients with renal anomalies.
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